Bausch Health Companies Net Income
| BHC Stock | USD 5.74 0.15 2.68% |
As of the 1st of February, Bausch Health shows the insignificant Risk Adjusted Performance, standard deviation of 3.53, and Mean Deviation of 2.49. Bausch Health Companies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Bausch Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.1737 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -64.8 M | -68 M | |
| Net Loss | -41.4 M | -43.5 M | |
| Net Loss | -64.8 M | -68 M | |
| Net Loss | (0.14) | (0.15) | |
| Net Loss | (0.32) | (0.30) |
Bausch | Net Income | Build AI portfolio with Bausch Stock |
Analyzing Bausch Health's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Bausch Health's current valuation and future prospects.
Latest Bausch Health's Net Income Growth Pattern
Below is the plot of the Net Income of Bausch Health Companies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bausch Health Companies financial statement analysis. It represents the amount of money remaining after all of Bausch Health Companies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bausch Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bausch Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (72 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Bausch Net Income Regression Statistics
| Arithmetic Mean | (505,719,812) | |
| Coefficient Of Variation | (274.68) | |
| Mean Deviation | 913,541,567 | |
| Median | (225,000,000) | |
| Standard Deviation | 1,389,135,685 | |
| Sample Variance | 1929698T | |
| Range | 6.6B | |
| R-Value | (0.06) | |
| Mean Square Error | 2050465.9T | |
| R-Squared | 0 | |
| Significance | 0.81 | |
| Slope | (17,019,207) | |
| Total Sum of Squares | 30875167.2T |
Bausch Net Income History
Other Fundumenentals of Bausch Health Companies
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Bausch Health Net Income component correlations
Bausch Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Bausch Health is extremely important. It helps to project a fair market value of Bausch Stock properly, considering its historical fundamentals such as Net Income. Since Bausch Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bausch Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bausch Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Pharmaceuticals sector continue expanding? Could Bausch diversify its offerings? Factors like these will boost the valuation of Bausch Health. Projected growth potential of Bausch fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bausch Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 13.68 | Earnings Share 1 | Revenue Per Share | Quarterly Revenue Growth 0.068 | Return On Assets |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bausch Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bausch Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bausch Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Bausch Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bausch Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bausch Health.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Bausch Health on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Bausch Health Companies or generate 0.0% return on investment in Bausch Health over 90 days. Bausch Health is related to or competes with HUTCHMED DRC, Perrigo Company, Concentra Group, Dentsply Sirona, Alvotech, Catalyst Pharmaceuticals, and Haemonetics. Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceuti... More
Bausch Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bausch Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bausch Health Companies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 22.08 | |||
| Value At Risk | (4.68) | |||
| Potential Upside | 6.2 |
Bausch Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bausch Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bausch Health's standard deviation. In reality, there are many statistical measures that can use Bausch Health historical prices to predict the future Bausch Health's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.07) |
Bausch Health February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 2.49 | |||
| Coefficient Of Variation | (6,292) | |||
| Standard Deviation | 3.53 | |||
| Variance | 12.49 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 22.08 | |||
| Value At Risk | (4.68) | |||
| Potential Upside | 6.2 | |||
| Skewness | 0.8068 | |||
| Kurtosis | 2.87 |
Bausch Health Companies Backtested Returns
Bausch Health Companies secures Sharpe Ratio (or Efficiency) of -0.0729, which signifies that the company had a -0.0729 % return per unit of risk over the last 3 months. Bausch Health Companies exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bausch Health's Standard Deviation of 3.53, mean deviation of 2.49, and insignificant Risk Adjusted Performance to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. Bausch Health returns are very sensitive to returns on the market. As the market goes up or down, Bausch Health is expected to follow. At this point, Bausch Health Companies has a negative expected return of -0.23%. Please make sure to confirm Bausch Health's value at risk, accumulation distribution, day typical price, as well as the relationship between the skewness and rate of daily change , to decide if Bausch Health Companies performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
Bausch Health Companies has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Bausch Health time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bausch Health Companies price movement. The serial correlation of -0.71 indicates that around 71.0% of current Bausch Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.71 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.47 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Bausch Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Bausch Health Companies reported net income of (72 Million). This is 121.1% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 112.61% higher than that of the company.
Bausch Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bausch Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bausch Health could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics of similar companies.Bausch Health is currently under evaluation in net income category among its peers.
Bausch Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bausch Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bausch Health's managers, analysts, and investors.Environmental | Governance | Social |
Bausch Health Institutional Holders
Institutional Holdings refers to the ownership stake in Bausch Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bausch Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bausch Health's value.| Shares | Macquarie Group Ltd | 2025-06-30 | 5.1 M | Hudson Bay Capital Management Lp | 2025-06-30 | 5 M | Ing Groep Nv | 2025-06-30 | 5 M | Mitsubishi Ufj Securities International Plc | 2025-06-30 | 3.4 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 3 M | Bnp Paribas Arbitrage, Sa | 2025-06-30 | 3 M | Arrowstreet Capital Limited Partnership | 2025-06-30 | 1.8 M | Charles Schwab Investment Management Inc | 2025-06-30 | 1.6 M | Private Management Group Inc | 2025-06-30 | 1.4 M | Icahn Carl C | 2025-06-30 | 34.7 M | Goldentree Asset Management Lp | 2025-06-30 | 34.3 M |
Bausch Fundamentals
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.0483 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 21.8 B | ||||
| Shares Outstanding | 370.52 M | ||||
| Shares Owned By Insiders | 10.68 % | ||||
| Shares Owned By Institutions | 64.00 % | ||||
| Number Of Shares Shorted | 5.03 M | ||||
| Price To Earning | 9.26 X | ||||
| Price To Book | 18.78 X | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 9.62 B | ||||
| Gross Profit | 7.09 B | ||||
| EBITDA | 3.13 B | ||||
| Net Income | (72 M) | ||||
| Cash And Equivalents | 1.18 B | ||||
| Cash Per Share | 1.34 X | ||||
| Total Debt | 21.83 B | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | (1.52) X | ||||
| Cash Flow From Operations | 1.6 B | ||||
| Short Ratio | 2.50 X | ||||
| Earnings Per Share | 1.00 X | ||||
| Price To Earnings To Growth | 0.63 X | ||||
| Target Price | 7.43 | ||||
| Number Of Employees | 20.7 K | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 2.13 B | ||||
| Total Asset | 26.52 B | ||||
| Retained Earnings | (9.82 B) | ||||
| Working Capital | (978 M) | ||||
| Current Asset | 984.02 M | ||||
| Current Liabilities | 730.59 M | ||||
| Net Asset | 26.52 B |
About Bausch Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bausch Health Companies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health Companies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Pharmaceuticals sector continue expanding? Could Bausch diversify its offerings? Factors like these will boost the valuation of Bausch Health. Projected growth potential of Bausch fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bausch Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 13.68 | Earnings Share 1 | Revenue Per Share | Quarterly Revenue Growth 0.068 | Return On Assets |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bausch Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bausch Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bausch Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.